Abstract | PURPOSE: Recent data have indicated that ⁶⁸Ga- DOTA-NOC positron emission tomography/X-ray computed tomography (PET/CT) may yield improved images in a shorter acquisition protocol than ¹¹¹In- DTPA- octreotide (OctreoScan®, OCT). Therefore, we performed a prospective comparison of ⁶⁸Ga- DOTA-NOC and OCT for the detection of neuroendocrine tumors (NETs). METHODS: Nineteen patients (eight carcinoid, nine pancreatic NETs, and two NE carcinoma of unknown origin) with previous positive OCT scans underwent ⁶⁸Ga- DOTA-NOC PET/CT and OCT single-photon emission computed tomography imaging for staging or follow-up. Findings were compared by region and verified with conventional imaging. RESULTS: All images of both modalities demonstrated focal uptake, often at multiple sites. ⁶⁸Ga- DOTA-NOC images were clearer than OCT images, facilitating interpretation. Similar foci were identified with both modalities in 41 regions, with additional foci on ⁶⁸Ga- DOTA-NOC in 21 and on OCT in 15 regions. CT, magnetic resonance imaging, or ultrasound confirmed the concordant findings in 31 of 41 regions and findings seen with ⁶⁸Ga- DOTA-NOC only in 15 of 21 regions. Findings seen with OCT only were less clear and were only confirmed in 4 of 15 regions. ⁶⁸Ga- DOTA-NOC had impact on staging in four patients and on management in three patients. CONCLUSIONS: Although ⁶⁸Ga- DOTA-NOC and OCT images were similar, in this study, ⁶⁸Ga- DOTA-NOC demonstrated more true positive tumor foci and was better tolerated by patients. This direct comparison supports replacement of OCT with ⁶⁸Ga- DOTA-NOC-PET/CT in the evaluation of NETs.
|
Authors | Yodphat Krausz, Nanette Freedman, Rina Rubinstein, Efraim Lavie, Marina Orevi, Sagi Tshori, Asher Salmon, Benjamin Glaser, Roland Chisin, Eyal Mishani, David J Gross |
Journal | Molecular imaging and biology
(Mol Imaging Biol)
Vol. 13
Issue 3
Pg. 583-593
(Jun 2011)
ISSN: 1860-2002 [Electronic] United States |
PMID | 20652423
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- 68Ga-DOTANOC
- Organometallic Compounds
- Somatostatin
- pentetreotide
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Female
- Humans
- Male
- Middle Aged
- Neuroendocrine Tumors
(diagnostic imaging)
- Organometallic Compounds
- Positron-Emission Tomography
- Somatostatin
(analogs & derivatives)
- Tomography, X-Ray Computed
|